payor coverage

NantHealth's net loss more than tripled in the second quarter, though it continues to build up its cash reserves.

Researchers concluded that there has been significant expansion of coverage for ctDNA assays over the past four years, but policies remain very heterogeneous and often limited.

Noridian is also developing a generic policy for donor-derived cfDNA tests that will include several commercially available tests, Natera said.

Under the guidance, group health plans and group and individual health insurers must cover diagnostic testing and other "certain related items and services."

A pathologists' group has pointed out that the bill covers only EUA tests, and patients receiving tests with pending regulatory status may receive surprise bills.

The insurer will cover testing at the Rady Children's Institute for Genomic Medicine for children in intensive care with unexplained medical conditions.

Palmetto has expanded coverage of the ClonoSeq assay to include monitoring MRD testing for patients with chronic lymphocytic leukemia (CLL.)